Michael Zeschnigk
Essen, NW 45122, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
GWAS meta-analysis provides new insights into uveal melanoma risk.
Journal: British journal of cancer
Published: December 04, 2025
Sorafenib as first-line therapy for metastatic uveal melanoma: A multicenter, placebo-controlled randomized discontinuation study (STREAM).
Journal: iScience
Published: May 23, 2025
No indications of weight gain associated DNA methylation changes in patients with anorexia nervosa.
Journal: Scientific reports
Published: January 09, 2025
Presence of tumor DNA in aqueous humor is correlated with high risk uveal melanoma.
Journal: Scientific reports
Published: December 21, 2024
The "oncological trace": circulating tumor DNA in uveal melanomas
Journal: Die Ophthalmologie
Published: July 31, 2024
Mass Spectrometry-Based Profiling of Histone Post-Translational Modifications in Uveal Melanoma Tissues, Human Melanocytes, and Uveal Melanoma Cell Lines - A Pilot Study.
Journal: Investigative ophthalmology & visual science
Published: February 13, 2024
Release of Cell-Free Tumor DNA in the Plasma of Uveal Melanoma Patients Under Radiotherapy.
Journal: Investigative ophthalmology & visual science
Published: October 20, 2023
Reduced Staphylococcus Abundance Characterizes the Lesional Microbiome of Actinic Keratosis Patients after Field-Directed Therapies.
Journal: Microbiology spectrum
Published: May 22, 2023
No evidence for intervention-associated DNA methylation changes in monocytes of patients with posttraumatic stress disorder.
Journal: Scientific reports
Published: August 03, 2021
Last Updated: 09/26/2026